The Importance of Regular STD Screenings: Why You Should Get Tested

Regular STD screenings are one of the most effective tools in sexual health — not because they treat anything, but because they catch infections before they cause complications. Most common STDs produce no symptoms for extended periods. Without testing, they silently damage fertility, increase HIV susceptibility, and spread to partners. The case for regular screening is not about risk behaviour; it is about how these infections actually work.

• Up to 75% of chlamydia infections in women produce no symptoms

• Untreated STDs are a leading preventable cause of infertility in both men and women

• STDs increase HIV acquisition risk by 2–10 times through genital inflammation

• Annual screening is recommended for all sexually active adults under 25

• Catching an STD early means simple treatment; missing it can mean permanent damage

Why Screenings Catch What Symptoms Miss

The fundamental problem with waiting for symptoms before testing is that symptoms are an unreliable indicator of STD status. Chlamydia — the most commonly reported STD in the US — is asymptomatic in up to 75% of women and a significant proportion of men. Gonorrhea shows no symptoms in the majority of women and up to 10% of men. HPV rarely causes symptoms other than warts, and most infections clear without ever being noticed. HIV can remain without symptoms for a decade or more. Herpes can persist indefinitely without a recognisable outbreak.

In each of these cases, the infection is present, active, and transmissible — while producing no warning. Testing is not a response to symptoms. It is a systematic check for infections that have specifically evolved to avoid triggering symptoms, because asymptomatic hosts transmit them more widely.

What Regular Screening Prevents

Infertility

Untreated chlamydia and gonorrhea are the most common preventable causes of tubal factor infertility in women. The bacteria ascend from the cervix to the fallopian tubes, causing Pelvic Inflammatory Disease and scarring that blocks the tubes. This damage is irreversible. In men, untreated infection can cause epididymitis and affect sperm quality. Regular testing catches these infections before they progress to PID.

HIV acquisition

Any STD that causes genital inflammation — chlamydia, gonorrhea, herpes, syphilis, trichomoniasis — increases HIV acquisition risk by disrupting the mucosal barrier that normally provides protection. The increase in risk ranges from approximately 2–5 times for bacterial infections to up to 10 times during active herpes outbreaks. Treating these infections through regular screening directly reduces HIV risk.

Congenital infection

Syphilis, chlamydia, gonorrhea, herpes, and HIV can all be transmitted from mother to baby during pregnancy or delivery. Syphilis causes stillbirth, severe disability, and death. Neonatal herpes is life-threatening. Chlamydia and gonorrhea cause neonatal eye infections that can lead to blindness. All of these outcomes are preventable with prenatal screening and treatment. The current epidemic of congenital syphilis in the US reflects failures in prenatal screening access, not the inherent difficulty of prevention.

Transmission to partners

An untreated person with chlamydia or gonorrhea will transmit it to sexual partners over months or years. Regular testing breaks this chain. It is one of the most direct public health benefits of individual screening: every person who tests and treats stops a transmission chain that would otherwise continue.

Who Should Screen and How Often

The CDC recommends annual chlamydia and gonorrhea testing for all sexually active women under 25, and for older women with new or multiple partners. HIV testing at least once in a lifetime for all adults aged 15–65, and annually for higher-risk individuals. Syphilis testing for pregnant women and anyone with multiple or new partners. Hepatitis C testing for all adults at least once. These are minimum recommendations — anyone with multiple partners, inconsistent condom use, or a partner diagnosed with an STD should test more frequently.

The Cost-Benefit Case

A standard STD screen costs far less than treating the complications of missed infections. A single IVF cycle — often necessitated by chlamydia-related tubal damage — costs $12,000–20,000 in the US. Ectopic pregnancy surgery and hospitalisation costs thousands more. HIV treatment, while now effective, requires lifelong medication. The economic case for regular screening is straightforward, independent of the personal health case.

Tips for Making Screening Routine

• Link it to another annual appointment — a GP check-up, a contraception review, or a gynaecology visit is a natural time to include STD screening.

• Use home testing kits if clinic attendance is a barrier — accurate, discreet, and available without a prescription for most common STDs.

• Set a calendar reminder — annual screening does not happen automatically; a standing reminder on the same date each year removes the friction.

• Test with a new partner — before stopping other protection in a new relationship, both partners testing together is the cleanest starting point.

• Ask for a comprehensive panel — standard panels vary. Ask specifically what is included and whether it covers HIV, syphilis, hepatitis, chlamydia, and gonorrhea.

Frequently Asked Questions

If I feel completely healthy, why do I need screening?

Because the most common STDs are designed by evolution to not make you feel sick. Chlamydia, gonorrhea, HPV, and herpes all persist without symptoms in many or most people. HIV can be present for years before causing any illness. Feeling healthy is not evidence of a negative STD status.

How is regular screening different from testing because of a concern?

Concern-based testing happens after a specific event — a broken condom, a partner disclosure, a symptom. Regular screening happens on a schedule regardless of specific events. Both are valuable, but only regular screening catches infections acquired between events you noticed. Most transmissions happen without any identifiable moment of concern.

Does regular screening mean I am high-risk?

No. The recommendations apply to all sexually active people within specific age groups and risk profiles, not only to people with high partner counts or specific behaviours. Sexual activity itself creates STD risk. Regular screening is the normal, responsible response to that baseline risk.

How often is often enough?

For most sexually active adults under 25 with occasional new partners: annually at minimum. For people with multiple partners or inconsistent condom use: every 3–6 months. For people on PrEP: every 3 months as required by the protocol. For people in stable, exclusive, tested relationships: a one-time baseline test at the start of the relationship, with retesting if circumstances change.

Can I be re-infected after a clear result?

Yes. A negative test reflects status at the time of testing and does not provide immunity. Chlamydia, gonorrhea, syphilis, and trichomoniasis can all be acquired again after successful treatment. This is why regular screening — not a single clean result — is the appropriate standard.

Get Screened Today

Regular STD screening is one of the simplest and most impactful things you can do for your long-term health. Fast, confidential testing is available at sexual health clinics, GP surgeries, and through home testing services.

Related reading: How Often Should You Get Tested? · Can You Have an STD With No Symptoms? · STD Testing Cost · What’s the Fastest Way to Get Tested?